For US residents only.
Click below for answers to some of the most frequently asked questions about JADENU® Sprinkle (deferasirox) granules and JADENU® (deferasirox) tablets for oral use.
If you are currently taking EXJADE® (deferasirox) tablets for oral suspension, for chronic iron overload, talk with your doctor about whether JADENU® Sprinkle (deferasirox) granules or JADENU® (deferasirox) tablets is a good alternative for you. Made from the same active ingredient as EXJADE, JADENU is also weight based, but the tablet vs granules strengths are slightly different. If your doctor decides that JADENU is right for you, your iron removal therapy will not be disrupted when you transition to JADENU. Talk to your doctor or nurse today.
You will be able to tell if JADENU is working by having your serum ferritin levels tested once a month or as directed by your doctor. Be sure to stay on top of treatment and get your iron levels tested once a month or as directed by your doctor. Treatment adjustments or interruptions may be needed if you experience any adverse events. Talk with your doctor about any side effects you experience.
Studies further evaluating the side effects of JADENU are ongoing. However, some common side effects associated with deferasirox, the active ingredient in JADENU, include nausea, vomiting, diarrhea, stomach pain, changes in kidney function, and skin rash.
Dose adjustment can occur for a number of reasons, including weight loss or gain, change in iron levels, or side effects. Ask your doctor or nurse if you have questions about a dose adjustment of any kind.
As results vary from patient to patient, only your doctor can decide how long you should be on treatment. JADENU is a long-term treatment regimen that can help lower your iron levels. As the dose is weight based, it is important to let your doctor know if you gain or lose weight so your medication can be adjusted. Be sure to also track your serum ferritin levels so you and your doctor can be aware of how JADENU is working. Inform your doctor if you experience any side effects.
Novartis is committed to helping patients receive the medicines they need. For more information about the different kinds of support programs available, visit the Financial Resources section of this site.
In April 2019 the first FDA-approved generic form of JADENU becomes available. Since that time, other manufacturers have been granted approval to produce generic forms of JADENU. Please speak with your doctor or pharmacist for more information.
If you and your doctor decide that branded JADENU is right for you, you can take these steps to ensure you receive it at every refill:
Your health insurance plan is an important factor in determining the out-of-pocket expenses for branded and generic medication. In addition, statutes related to a state or territory’s specific DAW requirements can affect your costs. Note that there may be a difference in cost between branded JADENU and generics.
Novartis is committed to making sure branded JADENU is available, but we can’t control what medications individual pharmacies stock. If your pharmacy doesn’t stock branded JADENU, you can ask the pharmacy to special order it for you, which usually can be delivered in a day.
Your medication costs can vary based on a variety of factors, such as insurance coverage and/or government assistance programs, and the costs set by the manufacturer. To learn more, call 1-800-282-7630 to speak with a member of our knowledgeable staff, and conduct a benefits investigation.
The pharmacy may substitute a generic form in place of branded JADENU. Talk to your doctor for more information. If you wish to remain on branded JADENU, you may request the pharmacist dispense as brand.
A generic may appear different from branded JADENU in characteristics such as pill shape, size, and color. In addition, now that there are multiple generic versions of JADENU, pill appearance may vary from refill to refill, depending on which generic the pharmacy has in stock. However, even though the generic pill may appear different, the FDA requires that generic medications contain the same active ingredient as the brand name, and that they function comparably in your body.
Your out-of-pocket costs may change based on your insurance plan design, or from other factors, which can change throughout the year. Novartis plans to continue financial support for eligible patients (including a $0 co-pay* offer for eligible, commercially insured patients). Other financial assistance may also be available. For help call 1-800-282-7630 to speak with a member of our knowledgeable staff dedicated to making access to therapy as simple and convenient as possible; or visit: www.PatientSupportMadeSimple.com.
Please contact the generic drug manufacturers or speak to your doctor or pharmacist with questions related to generic deferasirox.